Steve C. Penney

Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland.

SSG Private Debt Rated Notes II LP engages in pooled investment fund industry. The company is headquartered in Wilmington, DE.

Artefact Partners LLP is the hedge fund management subsidiary of Artefact Partners (Holding) Ltd. in Great Britain. The firm was founded by Richard Boon and Damian O'Brien in 2005. Headquartered in Wallington, Artefact Partners manages the assets of high-net-worth clients.

M&G Wealth Investment LLP (M&G Wealth) is an asset management firm headquartered in London, UK. Formerly TCF Fund Managers LLP, the firm was founded by Dan Norman and Gary Mairs in 2003 as Rutherglen Capital LLP. They were acquired by M&G Plc (LON: MNG; OTCMKTS: MGPUF) in 2022. M&G Wealth provides a variety of investment solutions to their clients.

SW1 Investors Ltd. (SW1) is the wholly-owned alternative investment subsidiary of Great Britain-based SW1 Capital LP, an integrated asset management business providing a range of investment solutions, including hedge funds and private equity investments. Formerly known as PCE Investors Ltd., the firm was established in 1997 as Pacific Chartered (Europe) Ltd. and changed their name in 2003 to PCE Investors Ltd. They are based in London and aim to realize investor value through a range of strategies and funds across asset classes and geographies. SW1 operates a client-focused business infrastructure which aligns interests between investors and fund managers. They operate their funds through a partnership ethos where portfolio managers are afforded independent investment creativity, economies of scale, the benefits of strong central business leadership and operational excellence.